Compare, Analyse ALEMBIC PHARMA with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
TEVA PHARMA
Dec-13
ALEMBIC PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs6642,973-   
Low Rs4122,582-   
Sales per share (Unadj.) Rs208.71,706.1-  
Earnings per share (Unadj.) Rs31.0106.6-  
Cash flow per share (Unadj.) Rs37.1244.5-  
Dividends per share (Unadj.) Rs5.5093.30-  
Dividend yield (eoy) %1.03.4 30.4%  
Book value per share (Unadj.) Rs144.21,895.1-  
Shares outstanding (eoy) m188.52848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.61.6 158.4%   
Avg P/E ratio x17.426.1 66.6%  
P/CF ratio (eoy) x14.511.4 127.7%  
Price / Book Value ratio x3.71.5 254.6%  
Dividend payout %17.787.5 20.3%   
Avg Mkt Cap Rs m101,4612,355,388 4.3%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m7,4670-   
Avg. sales/employee Rs ThNM32,189.6-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,010.9-  
INCOME DATA
Net Sales Rs m39,3471,446,763 2.7%  
Other income Rs m940-   
Total revenues Rs m39,4411,446,763 2.7%   
Gross profit Rs m8,736396,197 2.2%  
Depreciation Rs m1,152116,943 1.0%   
Interest Rs m18428,417 0.6%   
Profit before tax Rs m7,493250,837 3.0%   
Minority Interest Rs m111,140 0.9%   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m0-164,661 0.0%   
Tax Rs m1,568-3,062 -51.2%   
Profit after tax Rs m5,84490,378 6.5%  
Gross profit margin %22.227.4 81.1%  
Effective tax rate %20.9-1.2 -1,713.4%   
Net profit margin %14.96.2 237.7%  
BALANCE SHEET DATA
Current assets Rs m19,577977,138 2.0%   
Current liabilities Rs m14,896852,147 1.7%   
Net working cap to sales %11.98.6 137.7%  
Current ratio x1.31.1 114.6%  
Inventory Days Days9091 98.8%  
Debtors Days Days4596 47.3%  
Net fixed assets Rs m27,097472,545 5.7%   
Share capital Rs m3773,561 10.6%   
"Free" reserves Rs m26,8110-   
Net worth Rs m27,1881,607,079 1.7%   
Long term debt Rs m4,993739,762 0.7%   
Total assets Rs m47,7783,306,317 1.4%  
Interest coverage x41.79.8 424.4%   
Debt to equity ratio x0.20.5 39.9%  
Sales to assets ratio x0.80.4 188.2%   
Return on assets %12.63.6 351.1%  
Return on equity %21.55.6 382.2%  
Return on capital %23.64.9 478.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m13,3880-   
CASH FLOW
From Operations Rs m8,120230,539 3.5%  
From Investments Rs m-7,556-81,689 9.2%  
From Financial Activity Rs m590-276,547 -0.2%  
Net Cashflow Rs m1,153-127,697 -0.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.22 Rs / USD

Compare ALEMBIC PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare ALEMBIC PHARMA With: STRIDES PHARMA SCIENCE  ABBOTT INDIA  FDC LTD.  NOVARTIS  SUN PHARMA  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views On News

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9% (Quarterly Result Update)

May 9, 2019 | Updated on May 9, 2019

For the quarter ended March 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.6% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Oct 18, 2019 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS